Abstract:Cancer is one of the most dangerous threats to human health. One of the issues is drug resistance action, which leads to side effects after drug treatment. Numerous therapies have endeavored to relieve the drug resistance action. Recently, anticancer peptides could be a novel and promising anticancer candidate, which can inhibit tumor cell proliferation, migration, and suppress the formation of tumor blood vessels, with fewer side effects. However, it is costly, laborious and time consuming to identify anticancer peptides by biological experiments with a high throughput. Therefore, accurately identifying anti-cancer peptides becomes a key and indispensable step for anticancer peptides therapy. Although some existing computer methods have been developed to predict anticancer peptides, the accuracy still needs to be improved. Thus, in this study, we propose a deep learning-based model, called ACPNet, to distinguish anticancer peptides from non-anticancer peptides (non-ACPs). ACPNet employs three different types of peptide sequence information, peptide physicochemical properties and auto-encoding features linking the training process. ACPNet is a hybrid deep learning network, which fuses fully connected networks and recurrent neural networks. The comparison with other existing methods on ACPs82 datasets shows that ACPNet not only achieves the improvement of 1.2% Accuracy, 2.0% F1-score, and 7.2% Recall, but also gets balanced performance on the Matthews correlation coefficient. Meanwhile, ACPNet is verified on an independent dataset, with 20 proven anticancer peptides, and only one anticancer peptide is predicted as non-ACPs. The comparison and independent validation experiment indicate that ACPNet can accurately distinguish anticancer peptides from non-ACPs.

ACP-ST: An Anticancer Peptide Prediction Model Based on Learning Embedding Features and Swin-Transformer

ACP-DL: A Deep Learning Long Short-Term Memory Model to Predict Anticancer Peptides Using High-Efficiency Feature Representation

ACP-ML: A sequence-based method for anticancer peptide prediction

ACPScanner: Prediction of Anticancer Peptides by Integrated Machine Learning Methodologies

Prediction of Anticancer Peptides with High Efficacy and Low Toxicity by Hybrid Model Based on 3D Structure of Peptides

ACP-check: An anticancer peptide prediction model based on bidirectional long short-term memory and multi-features fusion strategy

Anticancer Peptide Prediction <i>via</i> Multi-Kernel CNN and Attention Model

Anticancer peptides prediction with deep representation learning features

Inacp: an Integrated Approach to the Prediction of Anticancer Peptides.

ACP-DA: Improving the Prediction of Anticancer Peptides Using Data Augmentation

Anti-Cancer Peptides Identification and Activity Type Classification with Protein Sequence Pre-training

iACP-DFSRA: Identification of Anticancer Peptides Based on a Dual-channel Fusion Strategy of ResCNN and Attention

MA‐PEP: A novel anticancer peptide prediction framework with multimodal feature fusion based on attention mechanism

Prediction of anticancer peptides based on an ensemble model of deep learning and machine learning using ordinal positional encoding

Contrastive learning for enhancing feature extraction in anticancer peptides

Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning

ACPNet: A Deep Learning Network to Identify Anticancer Peptides by Hybrid Sequence Information

ACPred-FL: a sequence-based predictor using effective feature representation to improve the prediction of anti-cancer peptides.

Integrating Multiple Sequence Features for Identifying Anticancer Peptides

EnACP: an Ensemble Learning Model for Identification of Anticancer Peptides

DeepACP: A Novel Computational Approach for Accurate Identification of Anticancer Peptides by Deep Learning Algorithm